A retrospective study analysing risk of massive submacular hemorrhage after initial treatment on polypoidal choroidal vasculopathy and its association with polyp regression
Latest Information Update: 07 Apr 2021
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Adverse reactions; Therapeutic Use
- 07 Apr 2021 New trial record